CARDIOVASCULAR INVOLVEMENTS IN BEHÇET'S DISEASE : "ANGIO-BEHÇET"
Behçet's disease is a relapsing, immune-mediated systemic vasculitis that may affect blood vessels of all types and sizes. Nowadays, the etiology remains unclear. In the absence of a biological marker or pathognomonic radiology, the diagnosis is mainly based on clinical manifestations. The cardiovascular involvement, known as "angio-Behçet", is relatively common and affects up to 40% of patients. It typi- cally occurs in a young male, usually during the onset of the disease. In general, immunosuppressive and anticoagulant therapies initiated early are likely to induce a remarkable cli- nical improvement. Nevertheless, prompt recognition of the polymorphous cardiovascular manifestations of the disease is challenging and may be responsible for some considerable delay prior to initiation of adequate therapy. The aim of this article is to describe the spectrum of cardiovascular involve- ments of Behçet's disease in order to optimize detection and therapeutic management.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
---|---|
Enthalten in: |
Revue medicale de Liege - 71(2016), 1 vom: 15. Jan., Seite 22-7 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
MANIFESTATIONS CARDIOVASCULAIRES DE LA MALADIE DE BEHÇET: "ANGIO-BEHÇET" |
---|
Beteiligte Personen: |
Tridetti, J [VerfasserIn] |
---|
Themen: |
Anticoagulants |
---|
Anmerkungen: |
Date Completed 05.04.2016 Date Revised 17.03.2016 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM258482451 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM258482451 | ||
003 | DE-627 | ||
005 | 20231224185114.0 | ||
007 | tu | ||
008 | 231224s2016 xx ||||| 00| ||fre c | ||
028 | 5 | 2 | |a pubmed24n0861.xml |
035 | |a (DE-627)NLM258482451 | ||
035 | |a (NLM)26983310 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Tridetti, J |e verfasserin |4 aut | |
245 | 1 | 0 | |a CARDIOVASCULAR INVOLVEMENTS IN BEHÇET'S DISEASE |b "ANGIO-BEHÇET" |
246 | 3 | 3 | |a MANIFESTATIONS CARDIOVASCULAIRES DE LA MALADIE DE BEHÇET: "ANGIO-BEHÇET" |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 05.04.2016 | ||
500 | |a Date Revised 17.03.2016 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Behçet's disease is a relapsing, immune-mediated systemic vasculitis that may affect blood vessels of all types and sizes. Nowadays, the etiology remains unclear. In the absence of a biological marker or pathognomonic radiology, the diagnosis is mainly based on clinical manifestations. The cardiovascular involvement, known as "angio-Behçet", is relatively common and affects up to 40% of patients. It typi- cally occurs in a young male, usually during the onset of the disease. In general, immunosuppressive and anticoagulant therapies initiated early are likely to induce a remarkable cli- nical improvement. Nevertheless, prompt recognition of the polymorphous cardiovascular manifestations of the disease is challenging and may be responsible for some considerable delay prior to initiation of adequate therapy. The aim of this article is to describe the spectrum of cardiovascular involve- ments of Behçet's disease in order to optimize detection and therapeutic management | ||
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Anticoagulants |2 NLM | |
650 | 7 | |a Immunosuppressive Agents |2 NLM | |
700 | 1 | |a Benoit, A |e verfasserin |4 aut | |
700 | 1 | |a Borgoens, P |e verfasserin |4 aut | |
700 | 1 | |a Hoffer, E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revue medicale de Liege |d 1947 |g 71(2016), 1 vom: 15. Jan., Seite 22-7 |w (DE-627)NLM000044490 |x 0370-629X |7 nnns |
773 | 1 | 8 | |g volume:71 |g year:2016 |g number:1 |g day:15 |g month:01 |g pages:22-7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 71 |j 2016 |e 1 |b 15 |c 01 |h 22-7 |